Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Haleon PLC ( (GB:HLN) ) has provided an update.
Haleon has repurchased 8,316,688 ordinary shares for cancellation under its ongoing buyback programme, with purchases executed between 11 and 15 May 2026 across venues including the London Stock Exchange and Cboe UK. Following these transactions, Haleon’s registered share capital stands at 8,871,945,578 ordinary shares, of which 12,130,560 are held in treasury, leaving 8,859,815,018 shares with voting rights, a key reference figure for shareholders’ disclosure obligations.
The buyback reduces the number of shares in circulation, potentially enhancing earnings per share and signaling management’s confidence in the company’s prospects. The updated capital and voting-rights structure also clarifies Haleon’s current equity base for investors and regulators, reinforcing transparency under UK market abuse and disclosure rules.
The most recent analyst rating on (GB:HLN) stock is a Buy with a £4.15 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on HLN Stock
According to Spark, TipRanks’ AI Analyst, HLN is a Neutral.
The score is driven primarily by solid financial performance (consistent free cash flow and improving profitability) and a cautiously positive earnings outlook supported by margin gains and cost savings. This is tempered by weaker near-term technical momentum and only moderate valuation support.
To see Spark’s full report on HLN stock, click here.
More about Haleon PLC
Haleon plc is a consumer health company focused on improving everyday health through a portfolio spanning oral health, vitamins, minerals and supplements, pain relief, respiratory, digestive and therapeutic skin health. Its leading brands, including Advil, Centrum, Panadol, Sensodyne and Voltaren, are used by more than one billion consumers worldwide and widely recommended by health professionals.
Average Trading Volume: 24,262,692
Technical Sentiment Signal: Sell
Current Market Cap: £29.52B
For detailed information about HLN stock, go to TipRanks’ Stock Analysis page.